Adamax

Description

Adamax (N-Acetyl Semax Analog / Adamantane-Modified Nootropic Peptide)

Molecular Formula: C₂₂H₅₂N₁₆O₆ (approximate) 
Molecular Weight: ~1,032.24 g/mol
Sequence: Ac-Met-Glu-His-Phe-Pro-Gly-Pro-Ala-Gly-NH₂ (Ac-MEHFPGP-AG-NH₂) 
CAS Number: [Not reliably confirmed] 
Purity: ≥98% (HPLC)
Form: Lyophilized Powder
Storage: Store at −20 °C. Protect from light and moisture.

Description

Adamax is a synthetic peptide analog derived from Semax, modified with an N-acetyl group at the N-terminus and an adamantane moiety at the C-terminus to enhance lipophilicity, stability, and brain-penetration.

It is designed for research on cognitive enhancement, neuroprotection, and synaptic plasticity. Pre-clinical sources suggest the compound may increase expression of Brain‑Derived Neurotrophic Factor (BDNF), enhance TrkB receptor sensitivity, promote neurogenesis, and support neural repair pathways. 

Because of its structural modifications, Adamax serves as a tool for studying how peptide analogs with enhanced brain-bioavailability can modulate neuronal connectivity, memory formation, and possibly neuro-degenerative pathways.

Intended Use

This product is intended for laboratory research use only.
It is not for human consumption, diagnostic, or therapeutic use.
All handling should be performed by qualified professionals in a controlled research environment.

Key Research Applications

• Investigation of modified nootropic peptides and analog-design for brain-penetrant activity

• Studies on synaptic plasticity, neurogenesis, and BDNF/TrkB signalling

• Research on neuroprotection, age-related cognitive decline, and neural repair mechanisms

• Analysis of structure–activity relationships of adamantane-modified peptides and lipophilic delivery systems